Thus, as a whole, our study has not demonstrated significant associations between the expression of EGFR, Cyclin-D1, p16, or p53 and age, gender, tumour site, stage, grade, size, nodal involvement, or metastasis in patients with non-oropharyngeal HNSCC. The gene discussed is TP53; the disease is neoplasm.